StockSelector.com
  Research, Select, & Monitor Thursday, July 20, 2017 8:33:34 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
United Therapeutics Corp.$131.25$1.29.99%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  United Therapeutics Corp. vs Drug Manufacturers/Other

UTD THERAPEUTIC is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. These products include pharmaceuticals, arginine products and telemedicine services.




Engaged in the discovery, development, and commercialization of innovative pharmaceuticals for the treatment of many diseases, either directly or indirectly. Directly treating a disease would involve some sort of drug that could attack the infection itself. An indirect treatment may involve a drug that's used to enhance the body's own antibody production so those antibodies can attack the infection themselves. Not only do some of these companies develop drugs for human use, a good number of them also work on animal or plant diseases as well.
 Totals Company Industry
  Sales: $1,598.8 Mil $100,433.1 Mil
  Market Cap: $5,567.6 Mil $406,061.1 Mil
  Analysts Recommendation: Hold Buy

 Averages Company Industry
 Growth
  Historic Revenue: 9.1% 41.6%
  Estimated Revenue: .1% 33.3%
  Historic Earnings: 19.9% (15.2%)
  Estimated Earnings: (13.2%) .4%
  Stock Price (1 Year): 18.4% 51.1%
  Cash per Share: 32.3% 6.1%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: 11.7 25.8
  Price-to-Sales: 3.5 N/A
  Price-to-Book: 3.0 5.9
  Dividend Yield: N/A N/A
  Market Cap: $5,567.6 Mil $12,304.9 Mil
  Operations
  Net Margin: 44.6% (138.4%)
  Gross Margin: 95.5% 82.6%
  Return on Equity: .4 (.5)
  Return on Assets: .3 21.7
  Balance Sheet
  Current Ratio: 4.3 5.9
  Quick Ratio: 4.0 5.6
  Cash Ratio: 3.2 4.9
  Debt-to-Equity: .3 3.9
  Interest Coverage: .6 2.2
 Technicals
  Relative-Strength Index: 54.4 N/A

 Other companies in Drug Manufacturers/Other Price Market Cap
  Novo Nordisk A\/S  (NVO) $42.57 $106,425.0 Mil
  Allergan, Inc.  (AGN) $246.41 $82,572.0 Mil
  UBS AG  (UBS) $17.77 $68,333.7 Mil
  Vertex Pharmaceuticals Inc.  (VRTX) $159.69 $39,714.9 Mil
  Teva Pharmaceutical Industries, Ltd  (TEVA) $31.92 $32,462.6 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.